129
Participants
Start Date
June 1, 2024
Primary Completion Date
June 30, 2025
Study Completion Date
August 30, 2026
Dexamethasone Combined with romiplostim N01
Dexamethasone (HD-DXM) at a dose of 40mg/d for 4 days constitutes one cycle. If there is no response on the 10th day, repeat it once. The administration can be either oral or intravenous. Meanwhile, romiplostim N01 is administered with an initial dose of 3µg/kg by subcutaneous injection once a week for up to 6 months.
Dexamethasone monotherapy
Dexamethasone (HD-DXM) 40mg/d × 4 days, one cycle. If there is no response on the 10th day, repeat once, administered either orally or intravenously.
RECRUITING
Chinese Academy of Medical Science and Blood Disease Hospital, Tianjin
Collaborators (1)
The Second Affiliated Hospital of Kunming Medical University
OTHER
Weifang People's Hospital
OTHER
Shenzhen Second People's Hospital
OTHER
The Affiliated Hospital of Qingdao University
OTHER
Changzhi Medical College
OTHER
Affiliated Hospital of Nantong University
OTHER
The First People's Hospital of Yunnan
OTHER
The First Affiliated Hospital of Bengbu Medical University
OTHER
Suining Central Hospital
OTHER
The Second Affiliated Hospital of Dalian Medical University
OTHER
North China University of Science and Technology
OTHER
Guizhou Provincial People's Hospital
OTHER
Institute of Hematology & Blood Diseases Hospital, China
OTHER